The field of cellular therapy is moving at breakneck speed. CAR-T, IEC, and other advanced therapy medicinal products (ATMPs) are revolutionizing patient care, transforming how we treat cancer and other diseases. Yet, with this incredible innovation comes a complex reality: managing the data of human cells as a raw material requires unprecedented precision.
STEMSOFT is a well-established division of , led by President and CEO Rob Fuller , and was founded in 1993 by Dr. Allen Eaves . Kana Lessig Stemsoft Software
(like StemLab or BMTserve).
all of their CAR-T, IEC, and research work. Ensure compliance with 21 CFR Part 11, HIPAA, and GDPR. The field of cellular therapy is moving at breakneck speed
As the industry moves from bench to bedside, the bottleneck often isn't the science—it’s the documentation. The Challenge of Modern Cellular Therapies STEMSOFT is a well-established division of , led